James Lamb

Featured in: Favicon

Articles

Magnetic Resonance Imaging Versus Computed Tomography Guidance for Stereotactic Body Radiotherapy in Prostate Cancer: 2-year Outcomes from the MIRAGE Randomized Clinical Trial

Nov 13, 2024 | europeanurology.com | James Lamb |Daniel Low |John Neylon |Ting Martin Ma

KeywordsProstateStereotactic body radiotherapyMagnetic resonance imaging guidanceWhat does this study add? These secondary analyses of a phase 3 randomized trial support the hypothesis that aggressive margin-reduction (AMR) using magnetic resonance imaging (MRI) to guide stereotactic body radiotherapy (SBRT) for prostate cancer reduces toxicity over the 2 yr following treatment.

Try JournoFinder For Free

Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.